StockData
Acrivon Therapeutics, Inc. logo

Acrivon Therapeutics, Inc. (ACRV) stock

ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.56+0.13 (+9.09%)

Close on Nov 18, 2026Market cap $66.85MP/E –Yield –

Acrivon Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Acrivon Therapeutics's market cap was $67.27M on Nov 11, 2026, against $74.46M a year earlier. Over the last 4 years it ranged from $20.67M to $445.42M, with a median of $89.52M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$67.27M-11.5%
2025Dec 31, 2025$76.03M-59.4%
2024Dec 31, 2024$187.41M+72.3%
2023Dec 29, 2023$108.75M+426.0%
2022Dec 30, 2022$20.67M–

More Acrivon Therapeutics figures

See a number that looks wrong?